Regeneron Pharmaceuticals's Revenue by Segment
In fiscal year 2025, Regeneron Pharmaceuticals's revenue by segment (products & services) are as follows:
- Collaboration Revenue: $7.33 B
- Product: $6.31 B
- Product and Service, Other: $702.60 M
Learn more about Regeneron Pharmaceuticals’s Revenue by Geography
Check out competitors to Regeneron Pharmaceuticals in a side-by-side comparison.
Explore additional financial metrics for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals's Revenue Share by Segment
| Collaboration Revenue | 5503100000 |
|---|---|
| Product | 7078000000 |
| Product and Service, Other | 536100000 |
| Collaboration Revenue | 6057800000 |
|---|---|
| Product | 7629200000 |
| Product and Service, Other | 515000000 |
| Collaboration Revenue | 7331200000 |
|---|---|
| Product | 6309100000 |
| Product and Service, Other | 702600000 |
The above chart shows Regeneron Pharmaceuticals's revenue percentage share by segment (products and services).
In fiscal year 2023, Regeneron Pharmaceuticals's revenue by segment is as follows:
- Collaboration Revenue generated $5.50 B in revenue, representing 41.95% of its total revenue.
- Product generated $7.08 B in revenue, representing 53.96% of its total revenue.
- Product and Service, Other generated $536.10 M in revenue, representing 4.09% of its total revenue.
The biggest segment for Regeneron Pharmaceuticals is the Product, which represents 53.96% of its total revenue.
The smallest segment for Regeneron Pharmaceuticals is the Product and Service, Other, which represents 4.09% of its total revenue.
The above chart shows Regeneron Pharmaceuticals's revenue percentage share by segment (products and services).
In fiscal year 2024, Regeneron Pharmaceuticals's revenue by segment is as follows:
- Collaboration Revenue generated $6.06 B in revenue, representing 42.65% of its total revenue.
- Product generated $7.63 B in revenue, representing 53.72% of its total revenue.
- Product and Service, Other generated $515.00 M in revenue, representing 3.63% of its total revenue.
The biggest segment for Regeneron Pharmaceuticals is the Product, which represents 53.72% of its total revenue.
The smallest segment for Regeneron Pharmaceuticals is the Product and Service, Other, which represents 3.63% of its total revenue.
The above chart shows Regeneron Pharmaceuticals's revenue percentage share by segment (products and services).
In fiscal year 2025, Regeneron Pharmaceuticals's revenue by segment is as follows:
- Collaboration Revenue generated $7.33 B in revenue, representing 51.11% of its total revenue.
- Product generated $6.31 B in revenue, representing 43.99% of its total revenue.
- Product and Service, Other generated $702.60 M in revenue, representing 4.9% of its total revenue.
The biggest segment for Regeneron Pharmaceuticals is the Collaboration Revenue, which represents 51.11% of its total revenue.
The smallest segment for Regeneron Pharmaceuticals is the Product and Service, Other, which represents 4.9% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Collaboration Revenue | 41.95% | 42.65% | 51.11% |
| Product and Service, Other | 4.09% | 3.63% | 4.9% |
| Product | 53.96% | 53.72% | 43.99% |
| Total Revenue | 100% | 100% | 100% |
Regeneron Pharmaceuticals's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Regeneron Pharmaceuticals.
In fiscal year 2025, the Collaboration Revenue generated the most revenue ($7.33 B), and the Product and Service, Other generated the least revenue ($702.60 M).
Regeneron Pharmaceuticals's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Collaboration Revenue | $5.50 B - |
$6.06 B
10.08%
|
$7.33 B
21.02%
|
| Product | $7.08 B - |
$7.63 B
7.79%
|
$6.31 B
17.30%
|
| Product and Service, Other | $536.10 M - |
$515.00 M
3.94%
|
$702.60 M
36.43%
|
| Total Revenue | $13.12 B - |
$14.20 B
8.27%
|
$14.34 B
0.99%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
